OpenAI and US FDA hold talks about using AI in drug evaluation, Wired reports
OpenAI has been quietly meeting with the U.S. FDA to explore how artificial intelligence could revolutionize regulatory processes, according to a Wired report on May 7. While the tech buzz centers on healthcare, here’s the twist for the paper packaging world: if AI streamlines FDA approvals, it could fast-track sustainable packaging innovations—like compostable food wraps or fiber-based pharma cartons—by cutting red tape. That means faster market entry and a competitive edge for paper over plastic. So yes, AI at the FDA might just be the unexpected accelerator for eco-friendly packaging breakthroughs.https://www.reuters.com/sustainability/boards-policy-regulation/openai-us-fda-hold-talks-about-using-ai-drug-evaluation-wired-reports-2025-05-07/
Comments
Post a Comment